87
Archived articleThis is an archived article from 2025 - please note that any content within the article may be out of date.

Daily Stock Market Report (Fri 18 July 2025) - CRPR, AGFX, BRBY, GSK, SNR, AT.

Good morning! 

To get started with we have a backlog section from Mark on James Cropper (LON:CRPR), which issued annual results yesterday.

It's a fairly quiet day for news today, so I'll aim to take a look at one or two backlog items from yesterday - including Ashtead Technology Holdings (LON:AT.).

Spreadsheet accompanying this report: link.

The agenda is now complete.

Report complete at 12.30: that's all we have time for today, enjoy your weekend.


Companies Reporting

Name (Mkt Cap)

RNS

Summary

Our view (Author)

BHP (LON:BHP) (£98bn)

Quarterly Activities Report

FY copper +8% to >2.0Mt, “record” iron ore prod. Jansen Stage 1 now exp $7-7.4bn vs $5.7bn prev.

GSK (LON:GSK) (£58bn)

Blenrep US ODAC outcome

SP -5%
The FDA’s Oncologic Drugs Advisory Committee (ODAC) has voted against proposed dosage of Blenrep for use to treat myeloma (a type of blood cancer). A final FDA decision on approval is due on 23 July 2025.
AMBER (Roland) [no section below]
I don’t follow pharma stocks closely as I lack the knowledge to understand their products in any detail. But today’s announcement does look disappointing. An expert committee of the US FDA has recommended against approving Blenrep, a new blood cancer treatment. A final decision from the FDA is expected next week, which analysts expect to mirror the committee’s recommendation.
GSK has previously said that Blenrep sales could reach over £3bn annually, which would be 9% of FY25E sales. So this was seen as a potentially important new blockbuster drug for the company. Applications to use Blenrep remain under review in most major markets, including the EU and China. I’m going to moderate our view to neutral, although I continue to think GSK as a whole is quite reasonably valued.

Reckitt Benckiser (LON:RKT) (£33.8bn)

Reckitt agrees to divest Essential Home

Selling to Advent PE for $4.8bn (7.7x EBIT). Plans $2.2bn special divi + share consolidation.

Burberry (LON:BRBY) (£4.5bn)

Q1 Trading Update

Retail rev -6% to £433m
LFL store sales -1%.
Contribution from space -1% (i.e. store closures)

Outlook: no specific guidance, improvements expected in H2.

AMBER (Roland)
Further revenue falls highlight the challenge that remains to rebuild customer desire, especially in the dominant Asian markets. I’m also concerned that the process of eliminating loss-making store space could be a costly and lengthy process. On the other hand, if CEO Joshua Schulman can reignite brand desire and resolve practical issues, I can see scope for a decent recovery. While my inclination is to be negative here, I think a fairer view might be to remain neutral until Schulman has had a little more time to deliver on his plans.

Bridgepoint (LON:BPT) (£2.9bn)

Half-Year Report

AUM +20% to $86.6bn at 30 June. Fee-paying AUM +2% to €37.5bn. Adj EBITDA -11.7% to £128.0m.

Smarter Web (OFEX:SWC) (£797m)

Result of Bookbuild Raising £17.5m

Raised £17.5m at 295p through a placing to institutional investors. Admission due on 23 July 25.

Senior (LON:SNR) (£788m)

Sale of Aerostructures business; Share Buyback

SP +9%
Selling for up to £200m (13.1x FY24 EBITDA) to a UK PE group. Initial consideration of £150m is expected to result in net cash proceeds of c.£100m.
This will be used to fund a £40m buyback and for debt repayment.
Transaction costs are expected to be £12m (!) and further contingent consideration of £50m is due in H1 2026, depending on FY25 EBITDA.
AMBER (Roland) [no section below]

Aerospace and defence group Senior reported in March that the sale of its Aerostructures business was at an advanced stage, so today’s news should not be a complete surprise.
Aerostructures has been affected by problems at Boeing. It was loss-making in 2024 and expected to generate an operating profit of £9-11m in 2025, suggesting that today’s purchase may be priced at c.20x FY FY25E EBIT.
Removing this until will leave Senior focused on “fluid conveyance and thermal management” solutions, which management say will result in structurally higher margins and improved ROCE.

The £40m buyback represents just under 5% of the share count after this morning’s rise, but Aerostructures was expected to contribute c.15% of group EBIT this year, from what I can see. So this looks slightly dilutive to earnings initially, but that might be offset by the benefits of debt reduction. Overall, the deal seems neutral or slightly positive to me. With the stock now trading on a high-teens multiple of FY26E earnings, I’m going to stay neutral ahead of the group’s next trading update and updated broker forecasts

Rentguarantor Holdings (OFEX:RGG) (£327m)

AIM Admission & withdrawal from AQSE

Planning to move listing from AQSE to AIM, effective 15 August 2025.
Altyngold (LON:ALTN) (£156m)H1 Operational UpdateGold poured +44% to 28.1koz, revenue +84% to $70.0m. On track for FY prod target of 50koz.

Crystal Amber Fund (LON:CRS) (£101m)

Fund Update

Rec’d final £18m relating to DLAR, total £40.7m. Main focus is now Morphic Medical reg. approvals.

Metals One (LON:MET1) (£36m)

Acquisition of Interest in Uranium Venture, USA

10% interest in NovaCore Exploration, which holds 15,000 acres in Red Basin, New Mexico.

Kavango Resources (LON:KAV) (£34m)

13.50g/t gold intercepted over 10.40m Bill’s Luck

Made high-grade gold intercept at Bill’s Luck mine, Zimbabwe: 13.6g/t over 10.4m, 111.4m deep.

Panthera Resources (LON:PAT) (£32m)

Bido Drilling Programme

Started Bido drilling (Burkina Faso); 1,740m drilling to test for continuity of earlier gold intercepts.

GSTechnologies (LON:GST) (£30m)

Notice of Arbitration on Semnet Pte. Ltd.

GST considers that sellers of Semnet have breached non-complete [sic] undertakings.

Atome (LON:ATOM) (£25m)

EIB approves $135m senior debt finance for Villeta

The EIB has agreed to support this green fertiliser project in Paraguay. FID now exp end September.

Great Southern Copper (LON:GSCU) (£16m)

Full Year Results

FY25: £4.2m net loss, £1m net cash. Outlook: planning drilling at Mostaza and Viuda Negra.

CAP-XX (LON:CPX) (£14m)

Update re. Collaboration with SCHURTER

Total pipeline “approaching” $2m. Achieved first design-win order. Focused on converting pipeline.

Argentex (LON:AGFX) (£3.3m) (suspended)

Announcement of VREQ

Following yesterday’s news that the company has failed to secure interim funding, Argentex has agreed with FCA to cease all regulated activity. This includes not onboarding new customers, not opening any new FX trades and taking all reasonable steps to stop incoming payments from existing customers.RED (Roland) [no section below]
These new restrictions appear to amount to a near-total ban on any continuing operations for Argentex. As Mark highlighted yesterday, this situation looks terminal and remaining shareholders will likely be questioning whether the IFX takeover at 2.5p per share is still going to proceed.

Backlog: James Cropper, Ashtead Technology Holdings


Roland's Section

Burberry (LON:BRBY) 

Up 4% to 1,298p (£4.7bn) - First Quarter Trading Update - Roland - AMBER

As a former shareholder I have been following Burberry’s turnaround efforts with interest. Unfortunately today’s first-quarter update seems inconclusive, at best, to me.

Today’s update covers the 13 weeks to 28 June 2025 and shows a further drop in revenue, together with underperformance from both new and existing stores:

  • Retail revenue -6% to £433m (-2% at constant exchange rates)

  • Comparable (LFL) store sales: -1%

  • Contribution from space: -1%; I take this to mean that store closure(s) resulted in lost sales

This seems to be a geographic story, with falling sales in China and Asia Pacific cancelling out some signs of progress in Western and Middle East markets:

AD_4nXegAJhWVI_LRSdm5md4aomvvld0UYd2BmMa9kKjFnN3DID7wujJvuMKHoSep6VWT7j2Gm9-zUrQnH42Ys48gIFL_UkrEVV-Dx_W9nm2p5V0h422aV9IPqIfghtNAvOABq9nWpaf9w?key=fUbJ6vg4UFoQtiPJNDfODg

The main problem with these numbers is that Burberry generated 44% of its revenue in Asia Pacific last year (including Greater China) and only 21% in the Americas. So the positive and negative sales figures in the table above do not simply offset each other.

The Americas and EMEIA will have a lot of heavy lifting to do to offset the decline in sales in China/Asia.

CEO Joshua Schulman understandably takes a positive note today, flagging up progress with his Burberry Forward strategy to rejuvenate the brand:

  • “Distinctive monthly campaigns - High Summer, Highgrove and Festival” to appeal to different customer segments

  • Rebalanced Autumn 25 collection, focused on “fewer, bigger ideas”

  • Improved visual merchandising in stores, higher product density, “scarf bar pilot outperforming fleet”

  • Online momentum

  • “Outperformance in outerwear and scarves and improved conversion”

All of this seems positive and I am confident that Burberry probably can improve on its baseline desirability by focusing on its core brand identity and on products where it has a distinctive appeal.

However, I have concerns about the ultimate growth potential of the business and the size and cost of its store estate. This is a risk Megan highlighted when she reviewed the company’s results in May.

Burberry’s FY25 accounts included impairment charges relating to 18 stores and showed net lease liabilities of £214m. This effectively indicates the expected scale of future losses from the store estate, based on management assumptions about future trading at the end of March 2025.

Of course, this may change if trading improves; year-end accounts are by their nature a momentary snapshot.

However, the negative contribution from space in today’s update suggests to me that Burberry is starting to close stores or reduce retail space where it’s able to. That seems sensible, but I think there’s a risk this process could be a drag on performance for some time to come.

Outlook: today’s update did not include any comment on Burberry’s performance versus full-year expectations.

Instead, CEO Schulman reiterated his (sensible) strategy and guided for some improvement in performance in H2:

Our focus this year is to build on the early progress we have made in reigniting brand desire, as a key requisite to growing the topline. In the first half we are continuing to prioritise investment and expect to see the impact of our initiatives build as the year progresses. We will deliver margin improvement with a continued focus on simplification, productivity and cash flow.

Roland’s view

Leaving aside the store estate, my main concern here is that demand from luxury buyers in Asia and China specifically will never return to the levels seen in the past.

The world has changed over the last decade and China’s domestic luxury market has matured and developed. From what I understand, there are now a growing number of coveted domestic luxury brands in China that offer an alternative to well-known western brands.

The other thing to consider is the valuation of this business. Historically, the shares tended to trade on a low-20s P/E ratio. Assuming a similar ratio in the future means that the current share price could imply earnings of 55-60p per share.

Forecasts for the next couple of years are much lower than this:

AD_4nXddyrz88gPwHcg9ls58_9l0WepLYlk_cPhvigok8bodoro5a5FG6civ_aRgUIk1BT6yGO7kRUR05SOcCbprvZEIWYb6oqN-YBm8bx9YoU9B3SMEhcy48N_8diY97artaLf41XgVBw?key=fUbJ6vg4UFoQtiPJNDfODg

These forecasts put Burberry on a FY26E P/E of 65, falling to a P/E of 32 in FY27.

Valuation estimates I’ve attempted in the past suggest to me that this business could be close to fair value already at current levels. However, I recognise that if the brand can regain momentum, strong operating leverage could support a strong recovery in profits.

My inclination is to take a negative view here, but on balance I think a fairer view might be to remain neutral until Mr Schulman has had a little more time to deliver on his plans. AMBER


Ashtead Technology Holdings (LON:AT.) - backlog

Down 21% to 353p (y’day) (£268m) - Half Year Trading Update - Roland - AMBER/RED (BLACK)

Ashtead Technology Holdings plc (AIM: AT.), a leading provider of subsea technology solutions to the global offshore energy sector, provides an update on trading for the six months ended 30 June 2025.

Yesterday’s half-year trading update appears to have been a profit warning, at least using some measures of profit (my emphasis):

The Board's view is that full year Adjusted EBITA will be modestly below its previous expectations whilst its expectations for adjusted profit before tax remain unchanged.

Ashtead Technology is essentially an equipment hire provider to the offshore oil and gas sector. It floated on AIM in 2021 and initially did well, before seemingly coming unstuck:

AD_4nXes5j9_vDpVKvxaWsmE0_ZJDKWmTNce4uxPgB5XB6TKJNd9ftKBfmQyfbqfQtAL1vvmd23c48lgN7BESedAPxfbq-eg6Z2QCOeodA8T0UEz69Sk1bTVjNcEK6YLLCW2mQY0TCp-fA?key=fUbJ6vg4UFoQtiPJNDfODg

This is a business where private investors seem to have been struggling for visibility over the last year or so. No broker notes are available on Research Tree. However, as Graham noted when he reviewed the interim results last September (when the shares fell sharply), there have not previously been any cuts to guidance.

As we can see from the consensus trend chart on the StockReport, this has remained true since then – right up until yesterday:

AD_4nXezmsfAed-iiCLtnqxclI6jmmkNh3A8F3l-Pq_b3NZsmIDfEY2VJPoCuSt8GDI6UDv_Gr8fxj7I2bcXVdlXtBBSN9AOO_8d-UxHJI_zijlrEjv68ucIHTl-0h_k4ydbrj7t0_o6?key=fUbJ6vg4UFoQtiPJNDfODg

Half-year update

Yesterday’s update covers the six months to 30 June 2025 seems to contain a mix of positive and negative points.

Revenue rose by 23% to approximately £99m during the half year, but also fell by 6% on a pro-forma basis. I believe this reflects the acquisitions of Seatronics and J2 Subsea in October 2024; it looks like the addition of revenue from these companies has offset falls elsewhere in Ashtead’s business.

The company admits that H1 saw “lower revenues than initially expected” and blames a number of factors:

  • Geo-political factors, including “significant disruption in the US market”;

  • Focus on higher quality rental revenues, pro-actively reducing exposure to lower-margin activities

Profit margins for the half year are reported at c.27.3%, on an adjusted EBITA basis (H1 24: pro forma 26.1%). Management say this is consistent with the group’s medium-term target of “high 20%’s”.

However, this performance continues the sequential decline in EBITA margins seen since 2023:

  • FY21: 25%

  • FY22: 28%

  • FY23: 32.8%

  • FY24: 29.9%

  • HY25: c.27.3%

One positive is that cost savings from the integration of Seatronics and J2 have apparently been both higher and quicker to achieve than originally expected.

Leverage: cash generation was in line with expectations and pro forma net leverage is expected to have been 1.6x EBITDA at the end of June.

This level of gearing shouldn’t be problematic unless profits fall further than expected, when it might become a concern.

Outlook & Estimates: there is some seasonality to this business and results are normally weighted to the second half.

The company now expects to report “high single digit percentage” revenue growth in H2, relative to H1.

Applying this to the H1 revenue figure of £99m suggests to me that full-year revenue could be c.£208m.

This is 9% below the consensus figure of £228m shown on the StockReport on 15 July (click on the arrow by the print button to access past StockReports).

Applying the H1 adj EBITA margin of 27.3% to these two revenue figures gives profit expectations of c.£57m and £62m, respectively. So we might speculate that this measure of profit is now expected to be about 8% lower than previously expected, perhaps a little less if margins improve at all.

I’m not going to try and recalculate earnings forecasts as the company’s unchanged pre-tax profit guidance makes this difficult. This seems to suggest that either finance costs or amortisation will be lower than previously expected, offsetting some of the weakness in earnings.

Personally, I suspect we may see consensus earnings forecasts for 2025 and 2026 slip slightly lower over the coming weeks, as analysts' reworked forecasts feed through.

I note from the news feed that brokers Berenburg and Peel Hunt both cut their price targets for Ashtead Technology yesterday.

Roland’s view

I would view yesterday’s update as a profit warning, certainly in terms of trading performance.

I’m tempted to take a neutral view here, as yesterday’s drop has left Ashtead trading on just seven times rolling 12-month forecast earnings:

AD_4nXe5icZafWuQ-mWuvNN7zUkR6iUwssenyuZmF4E1biVPT01kfiuGmkORbwUlyIBjhqSuawZyCTZfBGRhvEcuo9FeuAwClAuLlV_iEHuwfXF4TAYXS9uIV_1XdiUbNhE-4uPhho5Xsw?key=fUbJ6vg4UFoQtiPJNDfODg

A year ago, the stock was trading on a P/E of >20. At this level I think the business could be cheap, if past quality metrics can be maintained:

AD_4nXeLSfCYRopFyscCgZ3RlsQwv9eMhrJzHwEDWt1wlak1A_yPf569EFfAF2s3lsVJyFogcWsR7jIJ4eUtiO2LQu-oqSg_dEYis27w7ZJU_zeu-hXa2Aqi0jsGJCCEZYLPXH3GZv-eXQ?key=fUbJ6vg4UFoQtiPJNDfODg

However, I’m a little concerned about the apparent speed at which trading conditions seem to have worsened.

In its AGM Update on 22 May, the company said trading for the first four months of the year had been in line with expectations and made several points which seem to be at odds with yesterday’s statement:

  • “Record key customer backlogs provide confidence in future demand”

  • “While the macro business environment remains fluid, the Group's mobile and fungible technology fleet provides operational flexibility and helps navigate regional geopolitical market fluctuations.”

  • “The Board’s performance expectations for the full year remain unchanged”

I recognise that geopolitical events have moved fast over the last couple of months. But I can’t help wondering if the revenue weakness seen since May suggests some cyclical weakness is emerging in this sector. Are the key customers mentioned above cutting back on their orders?

The other risk I can see here is more general, based on our knowledge that a longer period of weakness often follows an initial profit warning.

For both of these reasons, I am going to go AMBER/RED on Ashtead Technology despite the possible cheapness of the shares.

We’ll aim to revisit this situation when the half-year results are published in August to see if a more positive view can be justified.


Mark's Section

James Cropper (LON:CRPR) - backlog

Up 11% to 260p (y'day) - Full Year Results - Mark - AMBER

This year, James Cropper have appointed the well-regarded CEO, David Stirling, formerly of Zotefoams. My view of his tenure there is less favourable than many. While he seemed good at selling the Zotefoams story to investors, taking on debt to build manufacturing capacity in a capex-heavy industry ahead of demand didn’t look sensible to me. And the new management at Zotefoams cancelled many of the “blue-sky” projects that were developed while he led the business.

With James Cropper he has a different challenge. Existing debt levels mean that capital discipline is enforced, and the weak performing part of the business is the legacy Paper & Packaging BU. Perhaps old habits die hard, as the headline for the RNS “Robust performance with new strategic direction” doesn't seem to match the sales figures:

Group revenue of £99.3m (FY24: £103.0m):
- 3% growth in Advanced Materials
- 7% decline in Paper & Packaging due to a change in product mix.

Profitability is improved through lower segmental losses at Paper & Packaging, plus higher profits at Advanced Materials:

AD_4nXc37QqyLn4MUzvsDx1Z4zL-LVRj1ZsPbNnczWrhn1H_mfk_PezVcNcB9OUWIsq4yiJjCjlgz2NNXNOvkE4TyjbSQGMxIwrwaNjmotT-uCovskbW_lzMPXlmvRnXqMIljQ_NE5TSlg?key=rbWZpG9inpR1V2lvoUoXWA

However, most of these gains seem to come from accounting for central costs differently. This confuses matters and makes it hard to determine where the improvement comes from, or how we should consider the business in a Sum of the Parts valuation (SOTP). There are also significant exceptional costs, although these are almost entirely non-cash impairments:

AD_4nXcJi_9d4393zculSLDX3ZkM6IdidlLRSfxsXY8DMbfj46pbzlNzYolPLCG50TyTQpESUM41jBDVvAdye24Lucse09ofu5MLZsee-NuM8EsanhJY7tPq-xiLJdNyNsok6KWatYgw?key=rbWZpG9inpR1V2lvoUoXWA

However, interest and pension deficit recovery payments are real cash payments. Net debt is down at the year end, but finance costs are up, suggesting this may not be a normal state of affairs:

AD_4nXeyw5eQaillejuxndfXuutPsZSUR7A1ciSpTRX131mZQ8r3vV0cN_UHnUg6AotTm5eLntWKZlZG-6TphL9nE-WM5A7f43hnVmhYI1_8Ac4EwTXfEkLGJR7k4cECRcRI1oWIfjWc_g?key=rbWZpG9inpR1V2lvoUoXWA

Outlook:

Last week they issued a slightly confusing trading statement where they said that Paper & Packaging was trading ahead of expectations in the first quarter, but these expectations were for losses. They think they will reach break even in the final quarter of the year. Something they reiterate in these results:

Trading in the first quarter was ahead of the Board's expectations and at a similar level to the strong start recorded in FY25. Despite headwinds from the loss of business at a merchant customer, referenced above, expectations are for Paper & Packaging to deliver a significant improvement in Adjusted EBITDA against FY25, and to achieve run-rate Adjusted EBITDA breakeven in the final quarter. The Advanced Materials business is expected to report high single-digit revenue growth for full year FY26, with planned operational cost investments during the period focused on revenue growth beyond FY26.

Three things complicate matters. The first is the change in allocation of central costs mentioned above. The second is the use of adjusted EBITDA, the adjustments can often do the heavy lifting in these matters. The third is the loss of a customer. They wouldn't be the first company to try to get out of losses by raising prices and seeing customers leave. If this is the case here (and I don’t know this, I’m just speculating about how these things often play out), we may have further customer losses putting pressure on the recovery.

Valuation:

Given the current state of affairs I think the mid-case is that Paper & Packaging is worth nothing. However, Advanced Materials is clearly a valuable business. Even allocating most of the central costs and applying a relatively modest 10x operating profit, this is a valuation of around £70m. From this we have to take off £13m net debt. There is a £16m IAS19 pension deficit. However, in any corporate transaction the pension trustees will demand a much higher payment to protect pensioners, probably £10m or so. This gives a SOTP valuation of around £30m, perhaps more if we are less conservative about the multiple we apply to Advanced Materials, versus a market cap of £25m. So there is a possible upside here. However, it requires management to be willing to take the difficult decision to close or sell Paper & Packaging for a nominal fee. This is a business still with founding family shareholders and a history that dates back to the 19th Century. They may simply be unwilling to take the steps necessary to break the group up.

Mark’s view

If management can take the difficult steps here, there is a valuable business underneath. However, the risk is that the good part of the business continues to subsidise the poor part, giving poor returns for shareholders overall. I’m not sure I’m willing to bet that management will be able to convince family shareholders to let go of a century old business for a nominal sum. It’s an AMBER for me.

Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

27 comments


Avatar for Tombholliday

Mark what are you talking about eps this year will be double that of 2019 reported eps for 2024 pre exceptional was 25 versus the 14 of 2019 Superficial or what 

0
Avatar for Monty9

Argentex (LON:AGFX) I doubt shareholders would particularly care about the failure of the 2.5p bid. What troubled me more is that it was not put into liquidation at the start.  Shareholders would perhaps have been better protected but more importantly the process would have provided much more clarity.  They would also have had a chance to sue the auditor for what turned out to be completely wrong risk analysis.

0
Avatar for The Boon Fund

James Cropper (LON:CRPR) is definitely not one for widows and orphans.

Main risks are three-fold.

  • Have they stemmed the losses from Paper, or will it continue? Loss of big volume from a customer is a blow. Will Chinese / Asian overcapacity (due to Tariffs) now flood the UK market?
  • Advanced Materials keeping its competitive edge. They have really high margins here to protect! Can a minnow really innovate and keep competitive against the big players? Obviously they are an advanced player when it comes to fibre-based tech, given their paper heritage. But is it enough?
  • Debt looks OK for now, but not super comfortable to covenants. Had to get covenant holiday last year.

The attractions are what keeps me invested:

  • AM on a standalone basis worth 2x+ the current market cap / EV in my opinion. I am more optimistic than Mark on this one.
  • AM has some potential unseen growth drivers at the moment. Hydrogen subsidies are booming in the UK, Germany, USA, and maybe more countries in the next 1-3 years. They might get an avalanche of orders. Defence and aerospace is another area that could see structural growth over years.
  • AM has a USA manufacturing plant. Presume they now have less competition from China, Europe players due to tariffs. Can increase volume, and stronger pricing.
  • Still trading below NTAV, which is 300p+ on a conservative basis.
  • Some other smaller points in my longer Substack write-up about James Cropper.

The red flag? The second and third above hasn't been mentioned at all in the last 2-3 updates. If they were genuine potential growth drivers, wouldn't management take the opportunity to squawk about them? But we get crickets. So maybe I'm wrong? They did have them on the slides during their Strategic Presentation though, but didn't spend any time verbally presenting it.

On the fence whether to sell and lock in my gains (I've been in since 157p, 60%+ gain) or hold out for my target (360p+). 

11
Avatar for Paul Hampson

Mike,

Thanks for the insightful piece on James Cropper James Cropper (LON:CRPR) . I hold but also as a local resident I take a personal interest. I have occasionally met Mark Cropper, on my way for a swim in his company reservoir, and what a nice guy he is! Or course I shouldn't let sentiment affect my investment decisions but in this case it probably does.

5
Avatar for Mark Simpson

Hi Paul,

I’m sure he is, and that may be part of the problem. While AM remains a great business the incentive to close or take drastic action on P&P is limited, especially if job losses are involved. TBF I’d back away from handing half my friends and neighbours their P45 in the interests of increasing shareholder value,   Perhaps over time AM will do well enough that people can just be moved from P&P and that wound down. The losses while that happens could be significant though. Hence why I’d put little value of that bit. But there’s a high degree of uncertainty about this and those taking the opposite view may do well if things turn out for the best.

Mark

4
Avatar for Mark Carter

Just my ramblings, don't take them too seriously ...

BRBY Revs down, I see. Market doesn't seem to mind, with shares up 2.4% in early trading. (Spoke too soon, now down 0.8%)

There's lots of debate on whether this is a dying brand, or a something else. People are worried about China, which is an important market. I read in a few places that brands tend to be cyclical. By that I mean one brand comes in favour, another out, but the one that goes out eventually comes back in.

On the balance of probabilities I'd say that the whole macro thing will sort itself out and the brand will come back into favour. I've no great conviction, though.

I think that the high PE is likely a good sign. It means that the market expects a recovery in the profits. This is perhaps inverted from the usual desire of buying low PE stocks.

I do remember famed investor Harry Nimmo touting Ted Baker as one of his favourite picks at one point. It was a disaster. The rag trade is a very very tricky business to get right.

I don't hold, but it's a story that I like to keep tabs on.

15
Avatar for SCI20

Burberry (LON:BRBY)

6
Avatar for bohenie

Mark I think your point harks back to one of the points Ed made on Wednesday evening - that in this day and age, there is no such stock as a 'hold forever'. Eventually stocks fall out of favour or in the case of Ted Baker an own goal.  Ive never understood the case for BRBY but thats probably my own ignorance. I did well out of Ted and no doubt there are plenty of examples we can call out.  But you are right that the rag trade is not for the feint hearted - Boohoo....

12
Avatar for Richard Leishman

#BRBY I wholeheartedly agree.  Once a fashion brand is damaged or goes "out of fashion" it's very hard to recover its previous lustre / following. To the woes of Ted Baker and Boohoo you could also add Superdry and ASOS.

9
Avatar for BnB

there is no such stock as a 'hold forever


If we define forever as 25 years, which seems to cover the asset-growing portion of a saver’s life, then in the UK, perhaps there are only a very few - I’d suggest Experian, RELX, AstraZeneca, Rightmove. But the US is stuffed full of them - and we’re  often talking a lot more than 25 years. 

4
Avatar for Rusty2

There are a few more that spring to mind: Ashtead (LON:AHT) Halma (LON:HLMA) and Diploma (LON:DPLM) these have all done well, over the last 20 years. No doubt there are others.

Yes more in the US but then there are many more stocks there. There was an article last year, l think, that said the UK a higher proportion of these type of stocks than the US.

4
Avatar for bohenie

Thats all fair comment - and hopefully these stocks mentioned will continue to produce excellent returns BUT I would not buy and forget, as I might have done in the past.

3
Avatar for 10Bagger

Next (LON:NXT) ?

3
Avatar for Spider1234

Morning All,

Burberry (LON:BRBY) still doesn't look very good to me!

6
Avatar for bensummers

You forgot Altyn PLC excellent trading update https://www.londonstockexchang...

6
Avatar for bensummers

btw it is a sad state of affairs when seemingly the only good companies to invest in the UK are gold mining stocks operating in foreign countries.

7
Avatar for Tombholliday

Mark if you look at the long term record of Zotefoams high performance foam revenues grew from £40000 in 2004 to 70m last year there are not many chief executives that can demonstrate such a growth record so your above commentary really is superficial 

6
Avatar for Mark Simpson

Hi Tom,

Maybe that was a great success, and maybe the rest of the business was just poor and in decline and he was fighting a battle against that. However, what shareholders care about is growing earnings, and that went nowhere for a decade:

ccce0f3d-f21b-4aaa-9dd2-dc11b2966e75.png

TBF the dividend growth wasn't too bad, but from a small base, and the payout ratio was relatively small suggesting that the business retained an awful lot of capital during this time in order to enable EPS to remain largely static. This wasn't the case of a business prioritising dividends over EPS growth. It had very little of either.

Of course, EPS at Zotefoams (LON:ZTF) is forecast to grow and the business looks in much better shape under the new managemnt. Perhaps he spent 20 years setting it up for their succes and then moved on before that was visible in the numbers. However, my superficial analysis on growing HP foams from £40k sales to £70m is he probably shouldn't have bothered as it didn't generate any real incremental earnings, at least over the last decade!

Controversial I know, but that's what the numbers are telling me, and I almost always take the numbers over the narrative .

Mark

14
Avatar for Lindsey Wright

What about Ocado from yesterday?

0
Avatar for Roland Head

Hi Lindsey,

Unfortunately there's not time to cover Ocado (LON:OCDO) today, but there was some discussion of this business in the comments yesterday, including a comment from Mark which I would broadly agree with. 

My view is that this business has always been heavily capital-intensive due to its practice of funding the development of new warehouses for its customers. This reduces its credibility as any kind of technology business. 

Having taken a quick look at the half-year results, I can see that cash is still flowing out of the business, which is not expected to reach cash flow breakeven until 2027. While the promised land of abundant free cash flow may be lurking over the horizon, this has been the case for many years.

Personally, I am inclined to remain sceptical about the investment appeal here.

All the best,

Roland

17
Avatar for Lindsey Wright

Thanks for the reply.  I was just surprised that the company had not even made it into the news of the day list!

0
Avatar for Harry Hindsight

A 'god spike' on the daily but still falling on the weekly chart. But one to watch. 400p alert. 

0
Avatar for Mike Berry

Could I please ask if you could take a look at Ashtead Technology Holdings (LON:AT.) from yesterday?

12
Avatar for Roland Head

Morning Mike,

Yes, I'm hoping to take a look at Ashtead Technology Holdings (LON:AT.) this morning as it's fairly quiet for news.

Roland

20
Avatar for Mike Berry

Thank you Roland

1
Avatar for Mike Berry

Thanks for that Review of Ashtead Technology Holdings (LON:AT.) - really useful.

5
Avatar for Harry Hindsight

The boat sank.

Don't like being cynical - I love the story - anything subsea is exciting, of national security importance, ie very important but we seem to 'cut our own throat' from top to bottom. 

Maybe the yanks and europeans trying to muscle in - so why not just buy them out.

0
Get the free newsletter